Other News To Note
Wednesday, October 2, 2013
• Bergenbio AS, of Bergen, Norway, published a paper in Blood identifying a significant role for the Axl receptor in progression and therapeutic resistance of acute myelogenous leukemia (AML).
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.